Results 11 to 20 of about 53,642 (189)
Human Vaccines & Immunotherapeutics, 2022 Nigeria has one of the highest measles burdens in the world. While measles-containing vaccine is proven to be effective in reducing measles cases, empirical studies on the correlation between measles incidence and measles vaccine coverage in Nigeria has ...
Ryoko Sato +3 more
doaj +1 more source
Shanghai yufang yixue, 2022 Measles is an acute respiratory infectious disease caused by the measles virus. It is highly infectious and easy to occur in children. It causes many serious complications such as tracheitis， otitis media and pneumonia. Since the promotion of the measles
SHEN Jinhua +4 more
doaj +1 more source
Molecular Therapy: Oncolytics, 2016 To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer +15 more
doaj +1 more source
Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]
PLoS ONE, 2017 The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng +7 more
doaj +1 more source
Molecular Therapy: Oncolytics, 2019 Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus.
Jan R.H. Hanauer +3 more
doaj +1 more source
The Influence of Quality of Measles Vaccine to The Incidence of Measles in Pasuruan Regency
Jurnal Berkala Epidemiologi, 2015 The measles is a major cause of child mortality among vaccine preventable disease. The incidence of measles reach out 198 cases in 2014 at Pasuruan. The incidence of measles in Pasuruan, not only in areas with low immunization coverage but also in areas ...
Dwi Wahyu Ningtyas, Arief Wibowo
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama +11 more
doaj +1 more source
Viral Immunology, 2018 Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was developed empirically by attenuation of wild-type (WT) MeV by in vitro passage in human and chicken cells and licensed in 1963.
openaire +2 more sources
EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS
Медицинская иммунология, 2014 . The review article considers different variants of measles vaccine that may be classified into two groups, i.e., vaccines that do not contain viable measles virus, and attenuated measles vaccines which could be employed in unusual manner.The first ...
V. A. Liashenko
doaj +1 more source
Measles vaccination of special risk groups
Human Vaccines & Immunotherapeutics, 2021 Measles is an important vaccine preventable disease with significant morbidity and mortality. Although measles vaccine is a safe and effective vaccine available worldwide for more than 50 years, still immunization efforts have not successfully reached ...
Vassiliki Papaevangelou
doaj +1 more source